Articles

FDA, gadolinium, MRI, contrast agents, GBCAs, safety, brain deposits

The U.S. Food and Drug Administration (FDA) is investigating the risk of brain deposits following repeated use of gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI)....

Aurora St. Luke's Medical Center in Milwaukee became the first hospital in the world to implement a new 4-D cardiovascular ultrasound technology. The software allows cardiologists to see chambers...

HeartMate PHP, percutaneous heart pump, St. Jude Medical, Thoratec

St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously approved a definitive agreement under which St. Jude Medical will acquire all of the...

A new study proves race and gender-related disparities exist in care for patients who have recently been diagnosed with atrial fibrillation (AF). The study, published in the July edition of Heart...

Boston Scientific, fully absorbable scaffold, FAST study, resorbable

Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully Absorbable Scaffold Feasibility Study (FAST) is a prospective, single-arm...

cardiac rehab after angioplasty, rehabilitation, ACC, Randal J. Thomas, referral

Hospitals in the Midwest were more likely than others to refer patients for guideline-recommended cardiac rehabilitation following angioplasty, according to new original research. This is...

ACC, health policy statement, heart team, cardiovascular health

Building teams that include advanced practice providers can help cardiovascular practices meet the challenges of modern practice, according to a new health policy statement by the American College...

NeoStem, PreSERVE study, AMI, ACC.15, NBS10, CD34 stem cells

NeoStem Inc. presented updated efficacy and safety results from the one-year follow-up for its Phase 2 PreSERVE study and additional analyses of certain functional tests at the American College of...

Thoratec, HeartMate PHP. CE Mark approval, SHIELD I

Thoratec announced that the HeartMate PHP (Percutaneous Heart Pump) received CE Mark approval, permitting sale in the European Union and other international countries. Approval was based on data...

The lag in FDA approval time for major medical innovations has come increasing concerns about the ability of the United States to remain at the forefront of research, especially in light of...